BLLN BillionToOne, Inc. — earnings, filings & institutional moves

Price chart

Daily historical data with per-account defaults

Latest close

$97.19

Period return

-7.47 (-7.14%)

Volume

879.3K

2026-06-05O $103.58 H $106.21 L $96.21 C $97.19MA5 $97.1MA20 $91.8MA60 $83.14MA120 $84.64

6M · 124 barsYahoo Finance · USD2025-12-08 → 2026-06-05

Recent event timeline

Filings, earnings, research, and institutional changes — newest first

View all →

2026. 05. 13.LowBUY24 days ago
Guggenheim: Buy
US analyst rating / recommendation change.
2026. 05. 08.LowBUYlast month
JP Morgan: Overweight
US analyst rating / recommendation change.
2026. 05. 07.LowBUYlast month
BTIG: Buy
US analyst rating / recommendation change.

Recent earnings

Consensus vs. actual, and revenue trend

Earnings tab →

Research actions

Consensus PT $117.71 · 7 analysts

Research tab →

AI Brief (Premium)

Automated summary from public sources · not investment advice

Brief tab →

No AI brief generated yet. You can create one from the Brief tab.

Top institutions (13F)

Ranked by position value

Institutions tab →

Company info

BillionToOne, Inc., a precision diagnostics company, quantifies biology to create molecular diagnostics. The company provides molecular counting platform, which is designed to detect and measure DNA molecules at the single-count level to help enhance disease detection. It also offers UNITY Complete, a non-invasive prenatal screen that assesses fetal risk for aneuploidies, recessive conditions, and fetal antigens from a maternal blood draw; Northstar Select, a liquid biopsy test that provides a list of mutations that are present in the tumor and types of mutations detected that include deletions, insertions, and point mutations; and Northstar Response, a methylation-based assay that quantifies the amount of cancer at the single molecule level without requiring a tissue biopsy, enabling real-time monitoring of patient response to therapy with unprecedented precision. BillionToOne, Inc. was incorporated in 2016 and is headquartered in Menlo Park, California.

Sector: Healthcare
Industry: Diagnostics & Research
HQ: Menlo Park, CA, United States
Fiscal year end: —
Employees: 713
IPO date: —

2026. 03. 31.LowBUY2 months ago

Guggenheim: Buy